Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

news.google.com

xofigo - Google News

Get the latest updates from xofigo - Google News directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 2 years ago

Precirix closes €80M series B with plans to complete phase II cancer trial - BioWorld Online

about 2 years ago

Precirix closes €80M series B with plans to complete phase II cancer...

SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence - Imaging Technology News

about 2 years ago

SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence  Imaging Technology News

Phase 3 KEYLYNK-010 Trial Examining Pembrolizumab/Olaparib in mCRPC to Stop for Futility - OncLive

about 2 years ago

Phase 3 KEYLYNK-010 Trial Examining Pembrolizumab/Olaparib in mCRPC to Stop for Futility...

SNMMI selects first Radiopharmaceutical Therapy Centers of Excellence - Health Imaging

about 2 years ago

SNMMI selects first Radiopharmaceutical Therapy Centers of Excellence  Health Imaging

Urological Cancer Therapeutics Drugs Market Analysis, Research Study With Ferring Pharmaceuticals, Indevus Pharmaceuticals Inc, GlaxoSmithKline plc – The Sabre - The Sabre

about 2 years ago

Urological Cancer Therapeutics Drugs Market Analysis, Research Study With Ferring Pharmaceuticals, Indevus...

Urological Cancer Drugs Market to Witness Growth Acceleration | AstraZeneca, Pfizer, Johnson and Johnson – The Sabre - The Sabre

about 2 years ago

Urological Cancer Drugs Market to Witness Growth Acceleration | AstraZeneca, Pfizer, Johnson...

SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence - EurekAlert

about 2 years ago

SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence  EurekAlert

Analysis of Genomic Alterations in Metastases Could Help Inform Treatment in RCC - OncLive

about 2 years ago

Analysis of Genomic Alterations in Metastases Could Help Inform Treatment in RCC...

Therapeutic Nuclear Medicines Market is projected to increase from a valuation of US$ 1 Billion in 2022 to US$ 1.84 Billion by 2028 - Digital Journal

about 2 years ago

Therapeutic Nuclear Medicines Market is projected to increase from a valuation of...

Urological Cancer Drugs Market Strategic Forecasting – Outlook By 2028 – corporate ethos - corporate ethos

about 2 years ago

Urological Cancer Drugs Market Strategic Forecasting – Outlook By 2028 – corporate...

Urologist offers pointers on implementing Jelmyto program - Urology Times

about 2 years ago

Urologist offers pointers on implementing Jelmyto program  Urology Times